278 related articles for article (PubMed ID: 23282971)
21. Prognosis in primary effusion lymphoma is associated with the number of body cavities involved.
Castillo JJ; Shum H; Lahijani M; Winer ES; Butera JN
Leuk Lymphoma; 2012 Dec; 53(12):2378-82. PubMed ID: 22591071
[TBL] [Abstract][Full Text] [Related]
22. [Human herpes virus 8-negative primary effusion lymphoma-like lymphoma recurring as a tumor adjacent to the left atrium].
Horiuchi M; Nakao T; Tsutsumi M; Nakaya Y; Fuseya H; Yoshida M; Yoshimura T; Hayashi Y; Fukushima H; Inoue T; Yamane T
Rinsho Ketsueki; 2019; 60(3):218-222. PubMed ID: 31068519
[TBL] [Abstract][Full Text] [Related]
23. Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(-) EBV(-) HHV8(+) patient.
Ozbalak M; Tokatlı I; Özdemirli M; Tecimer T; Ar MC; Örnek S; Koroglu A; Laleli Y; Ferhanoglu B
Eur J Haematol; 2013 Nov; 91(5):467-9. PubMed ID: 23865480
[TBL] [Abstract][Full Text] [Related]
24. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma.
Chadburn A; Hyjek E; Mathew S; Cesarman E; Said J; Knowles DM
Am J Surg Pathol; 2004 Nov; 28(11):1401-16. PubMed ID: 15489644
[TBL] [Abstract][Full Text] [Related]
25. Kaposi sarcoma herpesvirus/human herpesvirus 8-positive diffuse large B-cell lymphoma characterized by malignant ascites: A case report.
Chang LC; Fu PA; Wang SH; Chang KC; Hsu YT
Pathol Res Pract; 2024 Mar; 255():155185. PubMed ID: 38342036
[TBL] [Abstract][Full Text] [Related]
26. Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL).
Dai L; Trillo-Tinoco J; Bai L; Kang B; Xu Z; Wen X; Del Valle L; Qin Z
PLoS One; 2014; 9(2):e90349. PubMed ID: 24587336
[TBL] [Abstract][Full Text] [Related]
27. KSHV/HHV8-associated lymphomas.
Carbone A; Gloghini A
Br J Haematol; 2008 Jan; 140(1):13-24. PubMed ID: 17991301
[TBL] [Abstract][Full Text] [Related]
28. HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab.
Terasaki Y; Okumura H; Saito K; Sato Y; Yoshino T; Ichinohasama R; Ishida Y
Intern Med; 2008; 47(24):2175-8. PubMed ID: 19075546
[TBL] [Abstract][Full Text] [Related]
29. Kaposi Sarcoma With Intravascular Primary Effusion Lymphoma in the Skin: A Potential Pitfall in HHV8 Immunohistochemistry Interpretation.
Bruce-Brand C; Rigby J
Int J Surg Pathol; 2020 Dec; 28(8):868-871. PubMed ID: 32460596
[TBL] [Abstract][Full Text] [Related]
30. Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma.
Boulanger E; Daniel MT; Agbalika F; Oksenhendler E
Am J Hematol; 2003 Jul; 73(3):143-8. PubMed ID: 12827649
[TBL] [Abstract][Full Text] [Related]
31. KSHV/HHV8-mediated hematologic diseases.
Cesarman E; Chadburn A; Rubinstein PG
Blood; 2022 Feb; 139(7):1013-1025. PubMed ID: 34479367
[TBL] [Abstract][Full Text] [Related]
32. Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma.
Crane GM; Xian RR; Burns KH; Borowitz MJ; Duffield AS; Taube JM
J Cutan Pathol; 2014 Dec; 41(12):928-35. PubMed ID: 25355615
[TBL] [Abstract][Full Text] [Related]
33. The cytopathological spectrum of lymphomas in effusions in a tertiary center in Taiwan.
Wang RC; Chen YH; Chen BJ; Chuang SS
Diagn Cytopathol; 2021 Feb; 49(2):232-240. PubMed ID: 32975910
[TBL] [Abstract][Full Text] [Related]
34. [Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma that developed during myelodysplastic syndrome].
Aota Y; Maki S; Moriyama M; Udagawa S; Saihara M; Watanabe T; Fujiwara K; Okabe M; Yokoyama T; Sakurai M; Gotoh A
Nihon Ronen Igakkai Zasshi; 2021; 58(2):284-289. PubMed ID: 34039805
[TBL] [Abstract][Full Text] [Related]
35. HHV8-Negative Primary Effusion Lymphoma of B-Cell Lineage: Two Cases and a Comprehensive Review of the Literature.
Saini N; Hochberg EP; Linden EA; Jha S; Grohs HK; Sohani AR
Case Rep Oncol Med; 2013; 2013():292301. PubMed ID: 23401819
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
37. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas).
Drexler HG; Uphoff CC; Gaidano G; Carbone A
Leukemia; 1998 Oct; 12(10):1507-17. PubMed ID: 9766492
[TBL] [Abstract][Full Text] [Related]
38. HHV8-negative effusion based lymphoma: a series of 17 cases at a single institution.
Usmani A; Walts AE; Patel S; Alkan S; Kitahara S
J Am Soc Cytopathol; 2015; 4(1):37-43. PubMed ID: 31051672
[TBL] [Abstract][Full Text] [Related]
39. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature.
Adiguzel C; Bozkurt SU; Kaygusuz I; Uzay A; Tecimer T; Bayik M
APMIS; 2009 Mar; 117(3):222-9. PubMed ID: 19245595
[TBL] [Abstract][Full Text] [Related]
40. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
Schulz TF; Cesarman E
Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
